Patent SG-11201811273R-A (SG)
Title: Steviol glycoside compositions for oral ingestion or use
Inventor: CARLSON TING LIU
IPC: C13K1/00
Filed: 2016-11-30
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 111111111111111111111111111111111111111111111111111111111111111111111111 Organization International Bureau (10) International Publication Number (43) International Publication Date .....0\"\"\"1 WO 2017/218036 Al 21 December 2017 (21.12.2017) WIP0 I PCT (51) International Patent Classification: Kristopher T.; 13404 Oaland Drive, Burnsville, Minnesota A23L 27/00 (2016.01) C13K 1/00 (2006.01) 55337 (US). MORTENSON, Michael Alan; 23750 Sarah A23L 2/60 (2006.01) C13K 13/00 (2006.01) Circle, Rogers, Minnesota 55374 (US). SCHMELZER, (21) International Application Number: Wade Nolan; 3209 Edgewood Avenue South, St. Louis Park, Minnesota 55426 (US). YURTTAS, Nese; 865 Am- PCT/US2016/064274 ble Road, Shoreview, Minnesota 55126 (US). (22) International Filing Date: (74) Agent: WARMINSKY, Joshua M.; Cargill, Incorporat- 30 November 2016 (30.11.2016) ed, 15407 McGinty Road West, MS24, Wayzata, Minneso- (25) Filing Language: English to 55391 (US). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (30) Priority Data: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, 62/351,758 17 June 2016 (17.06.2016) US CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, 62/353,369 22 June 2016 (22.06.2016) US DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, 62/379,816 26 August 2016 (26.08.2016) US HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, (71) Applicant: CARGILL, INCORPORATED [US/US]; KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, 15407 McGinty Road West, Wayzata, Minnesota 55391 MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, (US). PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, (72) Inventors: CARLSON, Ting Liu; 55 Lakes Edge Way, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. _ Marietta, South Carolina 29661 (US). FALK, Nicole Lynn; 4016 Elliot Avenue S, Minneapolis, Minnesota 55407 (US). (84) Designated States (unless otherwise indicated, for every = GASPARD, Dan S.; 2550 Heron Lane, Victoria, Minnesota kind of regional protection available): ARIPO (BW, GH, 55386 (US). GUTHRIE, Brian D.; 8123 Stone Creek Dri- GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, ye, Chanhassen, Minnesota 55317 (US). MORTENSON, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, = — = = Title: STEVIOL GLYCOSIDE COMPOSITIONS FOR ORAL INGESTION OR USE — (54) = (57) : The present disclosure relates to compositions including steviol glycosides. The present disclosure also relates to sweetener compositions and sweetened compositions including steviol glycosides, and uses of such sweeten- er compositions to prepare sweetened compositions including food, beverages, = dental products, pharmaceuticals, nutraceuticals, and the like. = = = Compound ensue R,.(C-19) 1t2(043) = = 1. %viol H H = 2. Stiviohamide H L-010 =a, lia txilps{a Bac P-OL 4. anialbioside 6 BaL-0414(241) = P-C7a 13G kliota-n A Pae 011041 ( 24 1) = P-CM3 4 1) = B H 13110.0.01012.1) 1) LRal aeidaG 1) — .1) C. AsbouthasidAD P-G0-014/ 41 ) 0114-0424 I) 11 L-0143.1) 10. ripbeadioside El P.020-0K2-.1) 0-G14014240 M II. Robazdkulde F L•01D 4 3 . 41 ; o rf-a1c(31ni © 12.17.00oside A 04 3 / 2 , 04UA(2...1) GC 11 ei IN FIG. 1 1-1 0 ei C [Continued on next page] WO 2017/218036 Al MIDEDIMOMOIDEIRMEM00111MOIMIERVOIMIE TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, SK, SM, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3))